Vetted by NeuralPress's Multi-Agent Verifier for strict factual validity and event relevance. Our compliance engine cross-checks and filters search results to ensure zero false correlations or misleading content.
Primary Sources
Organ Sacks Could Replace Lab Animals, Startup Claims
San Francisco biotech startup R3 Bio is developing brain-free "bodyoids" — complete human organ systems grown from human cells — to replace laboratory animals in drug testing and eventually supply organs for transplantation. Backed by billionaire investors and aligned with the Trump administration's push to phase out animal experimentation, the company plans to progress from mouse models ...
Human 'organ sacks' could replace laboratory animals
A small group of scientists is angling to replace laboratory animals with living 'organ sacks' grown from human cells.
Inside the stealthy startup that pitched brainless human clones
That offered a path to a nearer-term business plan for more ethical medical experiments and toxicology testing—if the company could develop what it now calls monkey "organ sacks."
Silicon Valley startup backed by Tim Draper pitches growing brainless ...
The public face vs. the private pitch R3 Bio, founded by John Schloendorn, publicly presents itself as a company focused on creating nonsentient monkey "organ sacks" as alternatives to animal testing, as previously covered by Wired. But MIT Technology Review's investigation uncovered a more ambitious agenda: Schloendorn has actively pitched "brainless clones" — cloned human bodies ...
